
Jeeva Clinical Trials Inc. offers a unified, human-centric, AI-powered platform designed to simplify, streamline, and automate clinical trial workflows. Their software-as-a-service (SaaS) solution aims to increase efficiency and accessibility in clinical research for biopharmaceutical, medical device, and nutraceutical sponsors. The platform supports various study designs, from traditional to decentralized, and across therapeutic areas like oncology and rare diseases. Key features include electronic data capture (EDC), eCOA, eConsent, patient engagement portals, and trial management tools. Jeeva emphasizes rapid study configuration (within four weeks) and aims to reduce trial delays and costs, claiming up to 70% greater efficiency. They cater to emerging biotech and MedTech sponsors, aiming to break down barriers in clinical research and foster global inclusivity.

Jeeva Clinical Trials Inc. offers a unified, human-centric, AI-powered platform designed to simplify, streamline, and automate clinical trial workflows. Their software-as-a-service (SaaS) solution aims to increase efficiency and accessibility in clinical research for biopharmaceutical, medical device, and nutraceutical sponsors. The platform supports various study designs, from traditional to decentralized, and across therapeutic areas like oncology and rare diseases. Key features include electronic data capture (EDC), eCOA, eConsent, patient engagement portals, and trial management tools. Jeeva emphasizes rapid study configuration (within four weeks) and aims to reduce trial delays and costs, claiming up to 70% greater efficiency. They cater to emerging biotech and MedTech sponsors, aiming to break down barriers in clinical research and foster global inclusivity.
Product: AI-powered, unified clinical trial SaaS (CTMS, EDC, eConsent, eCOA, patient engagement, telehealth) for decentralized/hybrid trials
Founded: 2019
Founder & CEO: Dr. Harsha K. Rajasimha (PhD)
Headcount (approx.): 17 employees
Recent funding: Grant on 2023-06-27
Clinical trial operations and decentralization; patient recruitment, retention, and access across therapeutic areas including oncology and rare diseases.
2019
Biotechnology
75000
Commonwealth Commercialization Fund grant awarded to Jeeva Clinical Trials Inc.
“Commonwealth of Virginia, KiwiTech, Virginia Innovation Partnership Corporation, Virginia Venture Partners”